Eastman (EMN) Form 4: Director Eric Butler Purchases 3,000 Shares

Rhea-AI Filing Summary

Eric L. Butler, identified as a director of Eastman Chemical Co. (EMN), reported a purchase of 3,000 shares of Common Stock on 08/27/2025 at a price of $68.6525 per share. Following the transaction, the filing reports 9,330 shares beneficially owned, held directly. The Form 4 was signed by Power of Attorney Mark D. Austin on 08/28/2025.

Positive

• Director purchase disclosed: 3,000 shares acquired on 08/27/2025 at $68.6525, showing insider buying activity

Negative

• None.

Insights

Financial Analyst

Insider purchase recorded: small direct buy by a director; limited material effect on company valuation.

The Form 4 documents a straightforward open-market purchase of 3,000 common shares at $68.6525 by a director, increasing direct holdings to 9,330 shares. This is a routine disclosure required under Section 16 and contains no derivative transactions, option exercises, or other compensatory events. The size and nature of the transaction are explicit in the filing; no additional operational or financial data about Eastman Chemical is provided.

Corporate Governance Expert

Routine governance disclosure showing director buying shares; compliant Form 4 filed via POA.

The filing shows compliance with Section 16 reporting: transaction date 08/27/2025, filing executed by a Power of Attorney on 08/28/2025, and clear labeling of the reporter as a director. There are no amendments, no indirect ownership claims, and no unusual codes in the transaction line. The disclosure is complete for the transaction reported and contains no governance exceptions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BUTLER ERIC L

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		3,000	A	$68.6525	9,330	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Eric L. Butler	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did EMN director Eric L. Butler report on Form 4?

The Form 4 reports a purchase of 3,000 shares of Eastman Chemical Co. common stock on 08/27/2025 at $68.6525 per share.

How many shares does Eric L. Butler beneficially own after the reported transaction?

The filing shows Eric L. Butler beneficially owns 9,330 shares following the reported transaction.

What is Eric L. Butler's relationship to Eastman Chemical (EMN)?

The Form 4 identifies Eric L. Butler as a director of Eastman Chemical Co.

When was the Form 4 signed and by whom?

The Form 4 was signed by Mark D. Austin, by Power of Attorney for Eric L. Butler on 08/28/2025.

Were any derivative transactions or option exercises reported in this Form 4?

No. Table II for derivative securities contains no entries; only a non-derivative common stock purchase is reported.